Last Price
0.726
Today's Change
-0.029 (3.84%)
Day's Change
0.725 - 0.78
Trading Volume
20,626
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Joseph Sinkule Pharm.D. Dr. Joseph Sinkule Pharm.D.
Full Time Employees: 1 1
ISIN: US03465T1088 US03465T1088
Beta: 0.02 0.02
Last Dividend: 0.00 0.00
Dcf Diff: 0.87 0.87
Dcf: -0.15 -0.15
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.